The present invention is to provide modified release solid oral dosage form of topiramate or its pharmaceutically acceptable salts or derivatives which maintains an effective plasma drug concentration over an extended period of time and thereby maintain uniform and release rate of the active pharmaceutical ingredient over an extended period of time.